Evidence map›Paper›PMID 38244585›Full record

ArticleAging2024

Fang-Ming Wang, Li-Qiang Xu, Zhong-Chao Zhang, Qiang Guo, Zhi-Peng Du, Yue Lei, Xu Han, Chuang-Yan Wu, Feng Zhao, Jiu-Ling Chen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Fang-Ming WangDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li-Qiang XuDepartment of Cardiothoracic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhong-Chao ZhangDepartment of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Qiang GuoDepartment of Cardiothoracic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhi-Peng DuDepartment of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yue LeiDepartment of Blood Transfusion, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Xu HanDepartment of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chuang-Yan WuDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Feng ZhaoDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jiu-Ling ChenDepartment of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Huazhong University of Science and Technology · CNTaihe Hospital · CNUnion Hospital · CNHubei University of Medicine · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOverexpression of solute carrier family 7 member 8 (SLC7A8) has been shown to relate to the survival time and tumor progression in cancer patients. However, the role of

methodThe relationships between

resultsWe found that the expression of

conclusionThe downregulation of

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsAmino Acid Transport System y+Disease ProgressionFusion Regulatory Protein 1, Light ChainsHumansPrognosisAmino Acid Transport System y+Fusion Regulatory Protein 1, Light ChainsSLC7A8 protein, humanimmune infiltrationlung adenocarcinomaprognosisSLC7A8TCGA

Identifiers

PMID38244585
PMCPMC10866399
OpenAlexW4390975190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.